HomeAI · summaries
Storia in 2 fonti
Mylan exits Biocon with ₹3,679-crore stake sale; Biocon shares jump over 6%
Mylan, part of Viatris, exits Biocon by selling its 5.64% stake for ₹3,679 crore. Domestic mutual funds and global investors buy shares as Biocon gains over 6%.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
thehindubusinessline.com
Biocon to see block deals, as Viatris plans to exit
Viatris plans to sell a 5.64% stake in Biocon at a 7.9% discount, marking a complete exit.
- ·
economictimes.indiatimes.com
Biocon shares jump 6% as Mylan likely exits drugmaker after Rs 3,481 crore stake sale
Biocon shares experienced a significant jump of over 6% on Tuesday. Viatris-owned Mylan intends to sell a substantial stake, exiting the Indian drugmaker. This stake sale…
